State, Federal Lawmakers Aim to Bar PBMs From Owning Pharmacies - medpagetoday.com
Lawmakers are proposing to prohibit Pharmacy Benefit Managers (PBMs) from owning pharmacies, which could significantly alter the pharmacy landscape.
Aforeworn detected this change in the Pharmaceutical Manufacturing (FDA/DEA) space on August 8, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. All pharmacies and Pharmacy Benefit Managers (PBMs) operating in the state. should confirm how it applies to their specific situation before acting. There is a time constraint attached: TBD based on legislative schedule.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmaceutical Manufacturing (FDA/DEA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
Proposed legislation aims to bar PBMs from owning pharmacies, potentially affecting their business models and relationships with pharmacies.
Who it affects
All pharmacies and Pharmacy Benefit Managers (PBMs) operating in the state.
What you must do
Monitor the progress of the legislation and prepare for potential restructuring of business operations if passed.
Deadline
TBD based on legislative schedule.
Never miss a change like this again
Aforeworn watches Pharmaceutical Manufacturing (FDA/DEA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmaceutical Manufacturing (FDA/DEA)
- Senate Unanimously Passes Boscola-Backed Legislation to Modernize Pharmaceutical Licensing - pasenate.com
- USFDA flags 3 manufacturing compliance lapses at Lupin's New Jersey unit - Business Standard
- Comments on DEA’s proposed rule on manufacturing and procurement quotas - brookings.edu
- Arkansas passes law banning PBMs from owning pharmacies - Healthcare Dive
- State Marijuana Products Can Not Enter Schedule III Without Demonstrating the Chemical Consistency Required by Federal Regulation - newswire.com